Colgate-Palmolive CL
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 85th percentile, 5-year average 31.5x
#2314 of 2972 stocks by PE (1 = cheapest)
Above its usual level · 65th percentile, 5-year average -672.9x
#5297 of 5311 stocks by PB (1 = cheapest)
Around its usual level · 48th percentile, 5-year average 3.6x
#3445 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 263.23 | – | -672.87 | 65% (pricier than usual) | #5297 of 5311 (1 = cheapest) |
| PE | 37.08 | 23.83 | 31.53 | 85% (pricier than usual) | #2314 of 2972 (1 = cheapest) |
| PS | 3.56 | 3.48 | 3.59 | 48% (cheaper than usual) | #3445 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on CL.
Sign in to join the discussion.